• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淀粉样变性心脏病。

Amyloid heart disease.

机构信息

Harvard Vanguard Medical Associates, Harvard Medical School, Boston, MA 02215, USA.

出版信息

Prog Cardiovasc Dis. 2010 Jan-Feb;52(4):347-61. doi: 10.1016/j.pcad.2009.11.007.

DOI:10.1016/j.pcad.2009.11.007
PMID:20109604
Abstract

The systemic amyloidoses are an uncommon group of disorders characterized by the extracellular deposition of amyloid in one or more organs. Cardiac deposition, leading to an infiltrative/restrictive cardiomyopathy, is a common feature of amyloidosis. It may be the presenting feature of the disease or may be discovered while investigating a patient presenting with non-cardiac amyloidosis. In this article we review the features of cardiac amyloidosis and its varied manifestations. The need for a high index of suspicion and the critical importance of precise biochemical typing of the amyloid deposits is stressed in light of recent advances in therapy which can, when appropriately used, significantly improve prognosis.

摘要

系统性淀粉样变性是一组罕见的疾病,其特征是一种或多种器官中外源性淀粉样物质的沉积。心脏沉积导致浸润性/限制性心肌病,是淀粉样变性的常见特征。它可能是疾病的首发表现,也可能是在调查患有非心脏淀粉样变性的患者时发现的。本文回顾了心脏淀粉样变性的特征及其不同表现。鉴于最近在治疗方面取得了进展,如果适当地使用,这些进展可以显著改善预后,因此强调了对高度怀疑和精确生化分型淀粉样沉积物的重要性。

相似文献

1
Amyloid heart disease.淀粉样变性心脏病。
Prog Cardiovasc Dis. 2010 Jan-Feb;52(4):347-61. doi: 10.1016/j.pcad.2009.11.007.
2
Cardiac involvement with amyloidosis: mechanisms of disease, diagnosis and management.心脏淀粉样变性:发病机制、诊断与管理
Conn Med. 2011 Nov-Dec;75(10):581-90.
3
Cardiac amyloidosis: an approach to diagnosis and management.心脏淀粉样变性:诊断与管理方法
Expert Rev Cardiovasc Ther. 2010 Jul;8(7):1007-13. doi: 10.1586/erc.10.41.
4
Sudden cardiac death in infiltrative cardiomyopathies: sarcoidosis, scleroderma, amyloidosis, hemachromatosis.浸润性心肌病中的心脏性猝死:结节病、硬皮病、淀粉样变性、血色素沉着症。
Prog Cardiovasc Dis. 2008 Jul-Aug;51(1):58-73. doi: 10.1016/j.pcad.2007.10.003.
5
Cardiac amyloidosis: approaches to diagnosis and management.心脏淀粉样变性:诊断与治疗方法。
Cardiol Rev. 2010 Jan-Feb;18(1):1-11. doi: 10.1097/CRD.0b013e3181bdba8f.
6
Cardiac amyloidosis: updates in diagnosis and management.心脏淀粉样变性:诊断与治疗进展。
Arch Cardiovasc Dis. 2013 Oct;106(10):528-40. doi: 10.1016/j.acvd.2013.06.051. Epub 2013 Sep 23.
7
Cardiac amyloidosis.心脏淀粉样变性。
Clin Med (Lond). 2018 Apr 1;18(Suppl 2):s30-s35. doi: 10.7861/clinmedicine.18-2-s30.
8
[Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].[形成原纤维的蛋白质:淀粉样变性。心脏病专家必须了解的一种疾病的新希望]
Ital Heart J Suppl. 2002 Jun;3(6):590-7.
9
Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management.淀粉样心脏病。病理生理学、诊断和管理方面的新前沿与见解。
Tex Heart Inst J. 2005;32(2):178-84.
10
Cardiac amyloidosis: a practical approach to diagnosis and management.心脏淀粉样变性:一种实用的诊断和治疗方法。
Am J Med. 2011 Nov;124(11):1006-15. doi: 10.1016/j.amjmed.2011.04.013.

引用本文的文献

1
Clinical significance of the estimation of pulmonary-right ventricular uncoupling in patients with transthyretin amyloid cardiomyopathy.转甲状腺素蛋白淀粉样变心肌病患者肺-右心室解耦联评估的临床意义
Eur Heart J Imaging Methods Pract. 2025 Jan 17;3(1):qyae113. doi: 10.1093/ehjimp/qyae113. eCollection 2025 Jan.
2
Echocardiographic findings of patients with transthyretin amyloid cardiomyopathy.转甲状腺素蛋白淀粉样心肌病患者的超声心动图表现
J Echocardiogr. 2025 Mar;23(1):1-9. doi: 10.1007/s12574-024-00672-w. Epub 2024 Dec 27.
3
Assessing microvascular dysfunction and predicting long-term prognosis in patients with cardiac amyloidosis by cardiovascular magnetic resonance quantitative stress perfusion.
通过心血管磁共振定量应力灌注评估心脏淀粉样变性患者的微血管功能障碍并预测其长期预后。
J Cardiovasc Magn Reson. 2024 Dec 14;27(1):101134. doi: 10.1016/j.jocmr.2024.101134.
4
Automated Neural Architecture Search for Cardiac Amyloidosis Classification from [18F]-Florbetaben PET Images.基于[18F]-氟贝他班PET图像的心脏淀粉样变性分类的自动化神经架构搜索
J Imaging Inform Med. 2025 Jun;38(3):1452-1466. doi: 10.1007/s10278-024-01275-8. Epub 2024 Oct 2.
5
Diagnostic value of LGE and T1 mapping in multiple myeloma patients'heart.心脏 LGE 和 T1 mapping 对多发性骨髓瘤患者的诊断价值。
BMC Cardiovasc Disord. 2024 Apr 27;24(1):230. doi: 10.1186/s12872-024-03895-y.
6
Kinetic analysis of cardiac dynamic F-Florbetapir PET in healthy volunteers and amyloidosis patients: A pilot study.健康志愿者和淀粉样变性患者心脏动态F-氟代硼替吡PET的动力学分析:一项初步研究。
Heliyon. 2024 Feb 10;10(4):e26021. doi: 10.1016/j.heliyon.2024.e26021. eCollection 2024 Feb 29.
7
Biochemical and biophysical properties of a rare TTRA81V mutation causing mild transthyretin amyloid cardiomyopathy.导致轻度转甲状腺素蛋白淀粉样心肌病的罕见 TTRA81V 突变的生化和生物物理特性。
ESC Heart Fail. 2024 Feb;11(1):112-125. doi: 10.1002/ehf2.14543. Epub 2023 Oct 12.
8
Usefulness of automatic assessment for longitudinal strain to diagnose wild-type transthyretin amyloid cardiomyopathy.纵向应变自动评估对诊断野生型转甲状腺素蛋白淀粉样心肌病的效用。
Int J Cardiol Heart Vasc. 2023 Jun 22;47:101227. doi: 10.1016/j.ijcha.2023.101227. eCollection 2023 Aug.
9
Amyloidosis: What does pathology offer? The evolving field of tissue biopsy.淀粉样变性:病理学能提供什么?组织活检的发展领域。
Front Cardiovasc Med. 2022 Dec 5;9:1081098. doi: 10.3389/fcvm.2022.1081098. eCollection 2022.
10
Disease progression in cardiac morphology and function in heart failure: ATTR cardiac amyloidosis versus hypertensive left ventricular hypertrophy.心力衰竭中心脏形态和功能的疾病进展:ATTR 心脏淀粉样变性与高血压性左心室肥厚。
Heart Vessels. 2022 Sep;37(9):1562-1569. doi: 10.1007/s00380-022-02048-5. Epub 2022 Mar 11.